The ability of the immune system to make an enhanced response upon second exposure to an antigen is a central concept of immunology and the basis of vaccination against infectious diseases. Despite its fundamental and clinical importance, the underlying mechanisms of immunological memory remain poorly defined. A better understanding of memory is critical for the development of effective vaccination strategies. This proposal examines the mechanisms responsible for the generation and maintenance of CD8+ cytotoxic T lymphocyte (CTL) memory against viruses. CD8+ CTL play a role in controlling viral as well as intracellular bacterial and parasitic infections. Based on both experimental and clinical evidence, a strong case can be made that vaccines against intracellular pathogens should induce not only humoral responses but also induce long-term CD8+ T cell immunity.
The specific aims of this proposal are four-fold: ( i) To compare the efficacy of various antigen delivery systems in inducing long- term CTL memory. (ii) To examine the role of CD4+ T cells and B cells in the generation and maintenance of T cell memory. (iii) To determine if stimulation by MHC class I molecule or by the costimulatory molecules B7- 1/B7-2 is necessary for the maintenance of CTL memory. (iv) To analyze glycosylation changes in the cell surface molecules of naive, effector, and memory CD8+ T cells and to identify markers that will distinguish between effector and memory CTL. The experiments proposed in this grant should provide answers to three critical issues of immunological memory: (i) What type of vaccines induce long-term memory? (ii) How is memory maintained? and (iii) Are there any differences between effector and memory CTL? This information should provide a framework for the rational design of vaccines that elicit long- term protective CD8+ T cell immunity.
| Furuta, Yousuke; Komeno, Takashi; Nakamura, Takaaki (2017) Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase. Proc Jpn Acad Ser B Phys Biol Sci 93:449-463 |
| Araki, Koichi; Morita, Masahiro; Bederman, Annelise G et al. (2017) Translation is actively regulated during the differentiation of CD8+ effector T cells. Nat Immunol 18:1046-1057 |
| Youngblood, Ben; Hale, J Scott; Kissick, Haydn T et al. (2017) Effector CD8 T cells dedifferentiate into long-lived memory cells. Nature 552:404-409 |
| Lee, Junghwa; Hashimoto, Masao; Im, Se Jin et al. (2017) Adenovirus Serotype 5 Vaccination Results in Suboptimal CD4 T Helper 1 Responses in Mice. J Virol 91: |
| Ye, Lilin; Lee, Junghwa; Xu, Lifan et al. (2017) mTOR Promotes Antiviral Humoral Immunity by Differentially Regulating CD4 Helper T Cell and B Cell Responses. J Virol 91: |
| Kamphorst, Alice O; Wieland, Andreas; Nasti, Tahseen et al. (2017) Rescue of exhausted CD8 T cells by PD-1-targeted therapies is CD28-dependent. Science 355:1423-1427 |
| Ahn, Eunseon; Youngblood, Ben; Lee, Junghwa et al. (2016) Demethylation of the PD-1 Promoter Is Imprinted during the Effector Phase of CD8 T Cell Exhaustion. J Virol 90:8934-46 |
| Im, Se Jin; Hashimoto, Masao; Gerner, Michael Y et al. (2016) Defining CD8+ T cells that provide the proliferative burst after PD-1 therapy. Nature 537:417-421 |
| Kamphorst, Alice O; Araki, Koichi; Ahmed, Rafi (2015) Beyond adjuvants: immunomodulation strategies to enhance T cell immunity. Vaccine 33 Suppl 2:B21-8 |
| Lee, Junghwa; Ahn, Eunseon; Kissick, Haydn T et al. (2015) Reinvigorating Exhausted T Cells by Blockade of the PD-1 Pathway. For Immunopathol Dis Therap 6:7-17 |
Showing the most recent 10 out of 202 publications
